The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global BTK Inhibitor Market Research Report 2024

Global BTK Inhibitor Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1738357

No of Pages : 96

Ask Your Query

Synopsis
Bruton's tyrosine kinase (abbreviated Btk or BTK), also known as tyrosine-protein kinase BTK, is a tyrosine kinase that is encoded by the BTK gene in humans. BTK plays a crucial role in B cell development. Currently, BTK inhibitors are mainly applied in the treatments of hematological malignancies.

Global BTK Inhibitor market is projected to reach US$ 1817.5 million in 2029, increasing from US$ 886 million in 2022, with the CAGR of 10.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole BTK Inhibitor market research.

Key manufacturers engaged in the BTK Inhibitor industry include Pfizer, Aptose Eiosciences, BeiGene, Hanmi Phamaceutical, Eli Lilly, Merck, Ono Phamaceutical, AbbVie and Zhejiang DTRM Biopharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of BTK Inhibitor were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole BTK Inhibitor market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global BTK Inhibitor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Pfizer
  • Aptose Eiosciences
  • BeiGene
  • Hanmi Phamaceutical
  • Eli Lilly
  • Merck
  • Ono Phamaceutical
  • AbbVie
  • Zhejiang DTRM Biopharma
  • AstraZeneca
  • Biogen

Segment by Type

  • Tablet
  • Capsule

Segment by Application

  • Chronic Lymphocytic Leukemia (CLL)
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • Waldenstrom Macroglobulinemia
  • Other Selective B Cell Malignancies
  • Chronic Graft-versus-host Disease
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The BTK Inhibitor report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 BTK Inhibitor Market Overview
1.1 Product Overview and Scope of BTK Inhibitor
1.2 BTK Inhibitor Segment by Type
1.2.1 Global BTK Inhibitor Market Value Comparison by Type (2023-2029)
1.2.2 Tablet
1.2.3 Capsule
1.3 BTK Inhibitor Segment by Application
1.3.1 Global BTK Inhibitor Market Value by Application: (2023-2029)
1.3.2 Chronic Lymphocytic Leukemia (CLL)
1.3.3 Follicular Lymphoma
1.3.4 Mantle Cell Lymphoma
1.3.5 Waldenstrom Macroglobulinemia
1.3.6 Other Selective B Cell Malignancies
1.3.7 Chronic Graft-versus-host Disease
1.3.8 Others
1.4 Global BTK Inhibitor Market Size Estimates and Forecasts
1.4.1 Global BTK Inhibitor Revenue 2018-2029
1.4.2 Global BTK Inhibitor Sales 2018-2029
1.4.3 Global BTK Inhibitor Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 BTK Inhibitor Market Competition by Manufacturers
2.1 Global BTK Inhibitor Sales Market Share by Manufacturers (2018-2023)
2.2 Global BTK Inhibitor Revenue Market Share by Manufacturers (2018-2023)
2.3 Global BTK Inhibitor Average Price by Manufacturers (2018-2023)
2.4 Global BTK Inhibitor Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of BTK Inhibitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BTK Inhibitor, Product Type & Application
2.7 BTK Inhibitor Market Competitive Situation and Trends
2.7.1 BTK Inhibitor Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest BTK Inhibitor Players Market Share by Revenue
2.7.3 Global BTK Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 BTK Inhibitor Retrospective Market Scenario by Region
3.1 Global BTK Inhibitor Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global BTK Inhibitor Global BTK Inhibitor Sales by Region: 2018-2029
3.2.1 Global BTK Inhibitor Sales by Region: 2018-2023
3.2.2 Global BTK Inhibitor Sales by Region: 2024-2029
3.3 Global BTK Inhibitor Global BTK Inhibitor Revenue by Region: 2018-2029
3.3.1 Global BTK Inhibitor Revenue by Region: 2018-2023
3.3.2 Global BTK Inhibitor Revenue by Region: 2024-2029
3.4 North America BTK Inhibitor Market Facts & Figures by Country
3.4.1 North America BTK Inhibitor Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America BTK Inhibitor Sales by Country (2018-2029)
3.4.3 North America BTK Inhibitor Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe BTK Inhibitor Market Facts & Figures by Country
3.5.1 Europe BTK Inhibitor Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe BTK Inhibitor Sales by Country (2018-2029)
3.5.3 Europe BTK Inhibitor Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BTK Inhibitor Market Facts & Figures by Country
3.6.1 Asia Pacific BTK Inhibitor Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific BTK Inhibitor Sales by Country (2018-2029)
3.6.3 Asia Pacific BTK Inhibitor Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America BTK Inhibitor Market Facts & Figures by Country
3.7.1 Latin America BTK Inhibitor Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America BTK Inhibitor Sales by Country (2018-2029)
3.7.3 Latin America BTK Inhibitor Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa BTK Inhibitor Market Facts & Figures by Country
3.8.1 Middle East and Africa BTK Inhibitor Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa BTK Inhibitor Sales by Country (2018-2029)
3.8.3 Middle East and Africa BTK Inhibitor Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global BTK Inhibitor Sales by Type (2018-2029)
4.1.1 Global BTK Inhibitor Sales by Type (2018-2023)
4.1.2 Global BTK Inhibitor Sales by Type (2024-2029)
4.1.3 Global BTK Inhibitor Sales Market Share by Type (2018-2029)
4.2 Global BTK Inhibitor Revenue by Type (2018-2029)
4.2.1 Global BTK Inhibitor Revenue by Type (2018-2023)
4.2.2 Global BTK Inhibitor Revenue by Type (2024-2029)
4.2.3 Global BTK Inhibitor Revenue Market Share by Type (2018-2029)
4.3 Global BTK Inhibitor Price by Type (2018-2029)
5 Segment by Application
5.1 Global BTK Inhibitor Sales by Application (2018-2029)
5.1.1 Global BTK Inhibitor Sales by Application (2018-2023)
5.1.2 Global BTK Inhibitor Sales by Application (2024-2029)
5.1.3 Global BTK Inhibitor Sales Market Share by Application (2018-2029)
5.2 Global BTK Inhibitor Revenue by Application (2018-2029)
5.2.1 Global BTK Inhibitor Revenue by Application (2018-2023)
5.2.2 Global BTK Inhibitor Revenue by Application (2024-2029)
5.2.3 Global BTK Inhibitor Revenue Market Share by Application (2018-2029)
5.3 Global BTK Inhibitor Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer BTK Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer BTK Inhibitor Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Aptose Eiosciences
6.2.1 Aptose Eiosciences Corporation Information
6.2.2 Aptose Eiosciences Description and Business Overview
6.2.3 Aptose Eiosciences BTK Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Aptose Eiosciences BTK Inhibitor Product Portfolio
6.2.5 Aptose Eiosciences Recent Developments/Updates
6.3 BeiGene
6.3.1 BeiGene Corporation Information
6.3.2 BeiGene Description and Business Overview
6.3.3 BeiGene BTK Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BeiGene BTK Inhibitor Product Portfolio
6.3.5 BeiGene Recent Developments/Updates
6.4 Hanmi Phamaceutical
6.4.1 Hanmi Phamaceutical Corporation Information
6.4.2 Hanmi Phamaceutical Description and Business Overview
6.4.3 Hanmi Phamaceutical BTK Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hanmi Phamaceutical BTK Inhibitor Product Portfolio
6.4.5 Hanmi Phamaceutical Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly BTK Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Eli Lilly BTK Inhibitor Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck BTK Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck BTK Inhibitor Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Ono Phamaceutical
6.6.1 Ono Phamaceutical Corporation Information
6.6.2 Ono Phamaceutical Description and Business Overview
6.6.3 Ono Phamaceutical BTK Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ono Phamaceutical BTK Inhibitor Product Portfolio
6.7.5 Ono Phamaceutical Recent Developments/Updates
6.8 AbbVie
6.8.1 AbbVie Corporation Information
6.8.2 AbbVie Description and Business Overview
6.8.3 AbbVie BTK Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AbbVie BTK Inhibitor Product Portfolio
6.8.5 AbbVie Recent Developments/Updates
6.9 Zhejiang DTRM Biopharma
6.9.1 Zhejiang DTRM Biopharma Corporation Information
6.9.2 Zhejiang DTRM Biopharma Description and Business Overview
6.9.3 Zhejiang DTRM Biopharma BTK Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Zhejiang DTRM Biopharma BTK Inhibitor Product Portfolio
6.9.5 Zhejiang DTRM Biopharma Recent Developments/Updates
6.10 AstraZeneca
6.10.1 AstraZeneca Corporation Information
6.10.2 AstraZeneca Description and Business Overview
6.10.3 AstraZeneca BTK Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AstraZeneca BTK Inhibitor Product Portfolio
6.10.5 AstraZeneca Recent Developments/Updates
6.11 Biogen
6.11.1 Biogen Corporation Information
6.11.2 Biogen BTK Inhibitor Description and Business Overview
6.11.3 Biogen BTK Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Biogen BTK Inhibitor Product Portfolio
6.11.5 Biogen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BTK Inhibitor Industry Chain Analysis
7.2 BTK Inhibitor Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BTK Inhibitor Production Mode & Process
7.4 BTK Inhibitor Sales and Marketing
7.4.1 BTK Inhibitor Sales Channels
7.4.2 BTK Inhibitor Distributors
7.5 BTK Inhibitor Customers
8 BTK Inhibitor Market Dynamics
8.1 BTK Inhibitor Industry Trends
8.2 BTK Inhibitor Market Drivers
8.3 BTK Inhibitor Market Challenges
8.4 BTK Inhibitor Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock